Literature DB >> 20720024

Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia.

F Lamoth1, K Jaton, G Prod'hom, L Senn, J Bille, T Calandra, O Marchetti.   

Abstract

The frequent lack of microbiological documentation of infection by blood cultures (BC) has a major impact on clinical management of febrile neutropenic patients, especially in cases of unexplained persistent fever. We assessed the diagnostic utility of the LightCycler SeptiFast test (SF), a multiplex blood PCR, in febrile neutropenia. Blood for BC and SF was drawn at the onset of fever and every 3 days of persistent fever. SF results were compared with those of BC, clinical documentation of infection, and standard clinical, radiological, and microbiological criteria for invasive fungal infections (IFI). A total of 141 febrile neutropenic episodes in 86 hematological patients were studied: 44 (31%) microbiologically and 49 (35%) clinically documented infections and 48 (34%) unexplained fevers. At the onset of fever, BC detected 44 microorganisms in 35/141 (25%) episodes. Together, BC and SF identified 78 microorganisms in 61/141 (43%) episodes (P = 0.002 versus BC or SF alone): 12 were detected by BC and SF, 32 by BC only, and 34 by SF only. In 19/52 (37%) episodes of persistent fever, SF detected 28 new microorganisms (7 Gram-positive bacterial species, 15 Gram-negative bacterial species, and 6 fungal species [89% with a clinically documented site of infection]) whereas BC detected only 4 pathogens (8%) (P = 0.001). While BC did not detect fungi, SF identified 5 Candida spp. and 1 Aspergillus sp. in 5/7 probable or possible cases of IFI. Using SeptiFast PCR combined with blood cultures improves microbiological documentation in febrile neutropenia, especially when fever persists and invasive fungal infection is suspected. Technical adjustments may enhance the efficiency of this new molecular tool in this specific setting.

Entities:  

Mesh:

Year:  2010        PMID: 20720024      PMCID: PMC2953112          DOI: 10.1128/JCM.00147-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

1.  Candidemia in Norway (1991 to 2003): results from a nationwide study.

Authors:  Per Sandven; Lars Bevanger; Asbjørn Digranes; Hanne H Haukland; Turid Mannsåker; Peter Gaustad
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 2.  Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis.

Authors:  Stéphane Bretagne; Jean-Marc Costa
Journal:  FEMS Immunol Med Microbiol       Date:  2005-09-01

3.  Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.

Authors:  Brahm H Segal; Nikolaos G Almyroudis; Minoo Battiwalla; Raoul Herbrecht; John R Perfect; Thomas J Walsh; John R Wingard
Journal:  Clin Infect Dis       Date:  2007-01-02       Impact factor: 9.079

4.  Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies.

Authors:  Nicasio Mancini; Daniela Clerici; Roberta Diotti; Mario Perotti; Nadia Ghidoli; Donata De Marco; Beatrice Pizzorno; Thomas Emrich; Roberto Burioni; Fabio Ciceri; Massimo Clementi
Journal:  J Med Microbiol       Date:  2008-05       Impact factor: 2.472

5.  Enhanced and earlier detection of bacteremia and fungemia by multiplex polymerase chain reaction: how much enhanced, how much earlier, and at what cost?

Authors:  Matthew E Falagas; Panayotis T Tassios
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

6.  Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures.

Authors:  Susan E Beekmann; Daniel J Diekema; Gary V Doern
Journal:  Infect Control Hosp Epidemiol       Date:  2005-06       Impact factor: 3.254

7.  Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.

Authors:  C Viscoli; A Cometta; W V Kern; R Bock; M Paesmans; F Crokaert; M P Glauser; T Calandra
Journal:  Clin Microbiol Infect       Date:  2006-03       Impact factor: 8.067

Review 8.  Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients.

Authors:  H Einsele; J Loeffler
Journal:  Clin Microbiol Infect       Date:  2008-05       Impact factor: 8.067

9.  Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia.

Authors:  Richard F Louie; Zuping Tang; Timothy E Albertson; Stuart Cohen; Nam K Tran; Gerald J Kost
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

10.  Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.

Authors:  Nicole Blijlevens; Matthias Schwenkglenks; Pamela Bacon; Alessandra D'Addio; Hermann Einsele; Johan Maertens; Dietger Niederwieser; Werner Rabitsch; Ann Roosaar; Tapani Ruutu; Harry Schouten; Rebecca Stone; Samuel Vokurka; Barry Quinn; Shaun McCann
Journal:  J Clin Oncol       Date:  2008-02-11       Impact factor: 44.544

View more
  37 in total

1.  Multiplex PCR for rapid and improved diagnosis of bloodstream infections in liver transplant recipients.

Authors:  Peter-Michael Rath; Fuat Saner; Andreas Paul; Nils Lehmann; Eike Steinmann; Jan Buer; Joerg Steinmann
Journal:  J Clin Microbiol       Date:  2012-04-04       Impact factor: 5.948

2.  Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward.

Authors:  Leonella Pasqualini; Antonella Mencacci; Christian Leli; Paolo Montagna; Angela Cardaccia; Elio Cenci; Ines Montecarlo; Matteo Pirro; Francesco di Filippo; Emma Cistaro; Giuseppe Schillaci; Francesco Bistoni; Elmo Mannarino
Journal:  J Clin Microbiol       Date:  2012-02-08       Impact factor: 5.948

3.  Diagnostic performance and therapeutic impact of LightCycler SeptiFast assay in patients with suspected sepsis.

Authors:  V Herne; A Nelovkov; M Kütt; M Ivanova
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03-13

4.  Magicplex(TM) Sepsis Real-Time test to improve bloodstream infection diagnostics in children.

Authors:  Marco Denina; Carlo Scolfaro; Sara Colombo; Carmelina Calitri; Silvia Garazzino; Anna Barbui Anna; Silvia Brossa; Pier-Angelo Tovo
Journal:  Eur J Pediatr       Date:  2016-06-29       Impact factor: 3.183

5.  Evaluation of a commercially developed semiautomated PCR-surface-enhanced raman scattering assay for diagnosis of invasive fungal disease.

Authors:  P Lewis White; Samantha J Hibbitts; Michael D Perry; Julie Green; Emma Stirling; Luke Woodford; Graeme McNay; Ross Stevenson; Rosemary A Barnes
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

Review 6.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

7.  Molecular diagnosis of sepsis: New aspects and recent developments.

Authors:  O Liesenfeld; L Lehman; K-P Hunfeld; G Kost
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

8.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 9.  The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients.

Authors:  Jean Klastersky; Marianne Paesmans
Journal:  Support Care Cancer       Date:  2013-02-27       Impact factor: 3.603

10.  Broad-Range PCR Coupled with Electrospray Ionization Time of Flight Mass Spectrometry for Detection of Bacteremia and Fungemia in Patients with Neutropenic Fever.

Authors:  S Desmet; J Maertens; K Bueselinck; K Lagrou
Journal:  J Clin Microbiol       Date:  2016-07-20       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.